Last checked at 15 Nov 2017 12:08
ConvaTec Director Declaration
Reading, United Kingdom (15 November 2017)
ConvaTec Group Plc ("ConvaTec" or "the Company") announces that Dr Regina Benjamin, a Non-Executive Director of the Company, has been appointed as a Director of Computer Programs and Systems, Inc. ("CPSI"), a company listed on the US NASDAQ stock exchange, with effect from 9 November 2017.
This announcement is made in accordance with Listing Rule 9.6.14R.
Enquiries
Media
Bobby Leach, VP Group Corporate Affairs, ConvaTec +44 (0)7770 842 226
Alastair Elwen, Finsbury +44 (0)207 251 3801
Analysts and Investors
John Crosse, VP Investor Relations, ConvaTec +44 (0)7500 141 435
Kirsty Law, Director Investor Relations, ConvaTec +44 (0)7470 909 582
investorrelations@convatec.com
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.